Invention Grant
US08927508B2 Antibody production elicited by a DNA vaccine delivered by electroporation
有权
由通过电穿孔递送的DNA疫苗引起的抗体生产
- Patent Title: Antibody production elicited by a DNA vaccine delivered by electroporation
- Patent Title (中): 由通过电穿孔递送的DNA疫苗引起的抗体生产
-
Application No.: US12271603Application Date: 2008-11-14
-
Publication No.: US08927508B2Publication Date: 2015-01-06
- Inventor: Ruxandra Draghia-Akli , Amir S. Khan
- Applicant: Ruxandra Draghia-Akli , Amir S. Khan
- Applicant Address: US PA Plymouth Meeting
- Assignee: VGX Pharmaceuticals, Inc.
- Current Assignee: VGX Pharmaceuticals, Inc.
- Current Assignee Address: US PA Plymouth Meeting
- Agent Thomas Kim
- Main IPC: A61K48/00
- IPC: A61K48/00 ; C12N13/00 ; A61K39/12 ; A61K39/145 ; C12N15/87 ; A61K39/00

Abstract:
There are provided methods of generating antibodies in a mammal against recombinant antigens using DNA plasmids capable of expressing said antigens in cells of said mammal, comprising: injecting into tissue of said mammal a DNA plasmid comprising an encoding sequence operably linked to a promoter, electroporating said tissue with an electroporation device capable of delivering an electrical pulse effective to electroporate cells of said tissue to allow entry of said DNA plasmid and expression of said antigen, and allowing said mammal to respond to said expressed antigen in order to generate antibodies to said antigen. Furthermore, there are provided methods of isolating antibodies specific against desired antigens wherein said antibodies are generated in a mammal using DNA plasmids capable of expressing said antigens.
Public/Granted literature
- US20090156787A1 ANTIBODY PRODUCTION ELICITED BY A DNA VACCINE DELIVERED BY ELECTROPORATION Public/Granted day:2009-06-18
Information query